Target intelligence / Profile preview

Osmotic gradient across ocular tissues

Molecular classification
Other (physiological gradient/property; not a molecule, receptor, or protein)
01

Overview

The osmotic gradient across ocular tissues refers to the variation in osmotic pressure (typically arising from differences in ionic concentrations such as sodium, potassium, chloride, and osmolytes like taurine) between various regions of the eye, most notably between the vitreous, retina, retinal pigment epithelium (RPE), and choroid. This gradient is fundamental for regulating water movement and hydration, maintaining tissue transparency for optimal vision, and ensuring physiologic intraocular pressure. Changes in the osmotic gradient can influence the dynamics of aqueous humor outflow and tissue swelling (edema), and are manipulated therapeutically with hyperosmotic agents in conditions such as glaucoma and corneal edema. Unlike a discrete molecular target, the osmotic gradient is an emergent property of collective ion transport mechanisms, membrane channels (e.g., aquaporins, ion transporters), and systemic fluid balance. In summary, "osmotic gradient across ocular tissues" is a critical physiologic process but is not a conventional molecular target, and thus most structured drug-target information categories do not apply.

Other names
osmotic gradient in the eyeocular osmotic gradientcorneal tissue osmotic gradient
02

Mechanism of action

Hyperosmotic agents increase plasma osmolality, creating an osmotic gradient that draws water from ocular tissues into systemic circulation, thereby lowering IOP. Some agents influence aqueous humor production via central (CNS) osmoregulatory mechanisms.

03

Biological functions

Regulates water movement across ocular tissuesMaintains tissue hydration and transparencySupports optical clarity and phototransductionContributes to intraocular pressure (IOP) homeostasis
04

Disease associations

Glaucoma (disruption affects IOP regulation)Ocular hypotony (imbalance leads to effusion/oedema)Corneal edema (osmotic gradient affects tissue swelling/deswelling)Other vision-threatening conditions (by affecting hydration and pressure)
05

Safety considerations

Rebound IOP increase after osmotic agents due to equilibrium reversalExcessive dehydration of ocular tissues (may compromise tissue integrity or function)Transient effects—osmotic gradient changes are not always sustained and may require careful clinical management
06

Interacting drugs

Hyperosmotic agents (e.g., mannitol, glycerol)

2 more in the full profile.

Beyond the preview

Go deeper on Osmotic gradient across ocular tissues.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Osmotic gradient across ocular tissues.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call